Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio Key International (BKYI) Net Income towards Common Stockholders (2016 - 2025)

Bio Key International's Net Income towards Common Stockholders history spans 16 years, with the latest figure at -$964849.0 for Q3 2025.

  • For Q3 2025, Net Income towards Common Stockholders fell 30.57% year-over-year to -$964849.0; the TTM value through Sep 2025 reached -$4.3 million, up 19.58%, while the annual FY2024 figure was -$4.3 million, 49.53% up from the prior year.
  • Net Income towards Common Stockholders for Q3 2025 was -$964849.0 at Bio Key International, up from -$1.2 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at -$510285.0 in Q1 2024 and bottomed at -$5.0 million in Q4 2022.
  • The 5-year median for Net Income towards Common Stockholders is -$1.4 million (2024), against an average of -$1.6 million.
  • The largest annual shift saw Net Income towards Common Stockholders skyrocketed 75.55% in 2021 before it plummeted 146.35% in 2022.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at -$2.0 million in 2021, then plummeted by 145.56% to -$5.0 million in 2022, then soared by 52.38% to -$2.4 million in 2023, then soared by 41.65% to -$1.4 million in 2024, then skyrocketed by 30.31% to -$964849.0 in 2025.
  • Per Business Quant, the three most recent readings for BKYI's Net Income towards Common Stockholders are -$964849.0 (Q3 2025), -$1.2 million (Q2 2025), and -$736545.0 (Q1 2025).